Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Regan

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 19, 2000
Regression models and risk estimation for mixed discrete and continuous outcomes in developmental toxicologyM M Regan, P J Catalano
Biometrics|April 21, 2001
Likelihood models for clustered binary and continuous outcomes: application to developmental toxicologyM M Regan, P J Catalano
The American Journal of Clinical Nutrition|January 29, 2000
Cysteine kinetics and oxidation at different intakes of methionine and cystine in young adultsC A Raguso, M M Regan, V R Young
Journal of Virology|October 17, 2001
Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeuticsR A Parker, M M Regan, K A Reimann
Fertility and Sterility|December 4, 2001
Gender bias in the disposition of frozen embryosS Klipstein, R H Reindollar, M M Regan, et al.
Archives of Internal Medicine|April 10, 1995
Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgeryJ Menzin, G A Colditz, M M Regan, et al.
Medical Care|May 1, 1996
The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum")G Oster, T E Delea, D M Huse, et al.
The Annals of Pharmacotherapy|May 1, 1995
Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosisG Oster, D M Huse, M J Lacey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2022
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE studyG F Fleming, O Pagani, M M Regan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2022
Reply to the Letter to the Editor 'Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification' by Hannoun-Levi et alM A Franzoi, D Trapani, S Jezdic, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 19, 2000
Regression models and risk estimation for mixed discrete and continuous outcomes in developmental toxicologyM M Regan, P J Catalano
Biometrics|April 21, 2001
Likelihood models for clustered binary and continuous outcomes: application to developmental toxicologyM M Regan, P J Catalano
The American Journal of Clinical Nutrition|January 29, 2000
Cysteine kinetics and oxidation at different intakes of methionine and cystine in young adultsC A Raguso, M M Regan, V R Young
Journal of Virology|October 17, 2001
Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeuticsR A Parker, M M Regan, K A Reimann
Fertility and Sterility|December 4, 2001
Gender bias in the disposition of frozen embryosS Klipstein, R H Reindollar, M M Regan, et al.
Archives of Internal Medicine|April 10, 1995
Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgeryJ Menzin, G A Colditz, M M Regan, et al.
Medical Care|May 1, 1996
The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum")G Oster, T E Delea, D M Huse, et al.
The Annals of Pharmacotherapy|May 1, 1995
Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosisG Oster, D M Huse, M J Lacey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2022
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE studyG F Fleming, O Pagani, M M Regan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2022
Reply to the Letter to the Editor 'Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification' by Hannoun-Levi et alM A Franzoi, D Trapani, S Jezdic, et al.
Pageof 6